GREAT POINT PARTNERS LLC
Filing Date
Global Rank
#3,827
/ 7,976
▲ 854
Top Industry
Biotechnology
90.3%
3Y Alpha vs SPY
-4.3%
Period ended 9 months ago
Filed Nov 14, 2025 · 7mo
23 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+60.2%
SPY
+76.5%
Annualised alpha
-3.8%
Max drawdown
−61.9%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
29 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025Top Position
9.7%
−3.7 pts
Top 5
40.0%
−6.7 pts
Top 10
64.6%
−5.2 pts
HHI
537
Diversified−107
Portfolio Trend
23 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $237,565,982 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
4 positions
Trimmed
Positions the filer reduced
6 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ABVX | Abivax S.A. | −1,141,617 | 150,000 | $12,735,000 | |
| RZLT | Rezolute, Inc. | −581,653 | 2,451,809 | $23,047,004 | |
| IONS | Ionis Pharmaceuticals Inc | −420,000 | 80,000 | $5,233,600 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | −300,000 | 1,700,000 | $23,103,000 | |
| LEGN | Legend Biotech Corp | −236,540 | 113,460 | $3,699,930 | |
| NGNE | Neurogene Inc. | −39,045 | 446,814 | $7,743,286 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
12 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| NKTR | Nektar Therapeutics | 300,000 | $17,070,000 | |
| SLNO | Soleno Therapeutics Inc | 225,000 | $15,210,000 | |
| ASND | Ascendis Pharma A/S | 75,000 | $14,910,750 | |
| APGE | Apogee Therapeutics, Inc. | 304,000 | $12,077,920 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 265,803 | $10,459,348 | |
| EPRX | Eupraxia Pharmaceuticals Inc. | 1,200,000 | $7,080,000 | |
| PHVS | Pharvaris N.V. | 155,105 | $3,869,869 | |
| ORKA | Oruka Therapeutics, Inc. | 183,330 | $3,525,435 | |
| SANA | Sana Biotechnology, Inc. | 700,000 | $2,485,000 | |
| ABSI | Absci Corp | 796,438 | $2,421,171 | |
| HRMY | Harmony Biosciences Holdings, Inc. | 85,000 | $2,342,600 | |
| CAPR | Capricor Therapeutics, Inc. | 87,700 | $632,317 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
6 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. | 1,985,915 | $7,228,730 | |
| EOLS | Evolus, Inc. | 720,118 | $6,632,286 | |
| ACLX | Arcellx, Inc. | 100,000 | $6,585,000 | |
| KALV | KalVista Pharmaceuticals, Inc. | 323,170 | $3,653,436 | |
| CNTA | Centessa Pharmaceuticals plc | 225,000 | $2,956,500 | |
| SRRK | Scholar Rock Holding Corp | 61,607 | $2,182,119 | |
| No positions match the current search. | ||||
29 positions ·
$237,565,982 total
· as of Sep 30, 2025
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
Reduced | 1,700,000 | $23,103,000 | 9.72% | |
| RZLT |
Rezolute, Inc.
Healthcare
|
Reduced | 2,451,809 | $23,047,004 | 9.70% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
NEW | 300,000 | $17,070,000 | 7.19% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
Added | 3,815,930 | $16,522,976 | 6.96% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
NEW | 225,000 | $15,210,000 | 6.40% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
NEW | 75,000 | $14,910,750 | 6.28% | |
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 150,000 | $12,735,000 | 5.36% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
NEW | 304,000 | $12,077,920 | 5.08% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
NEW | 265,803 | $10,459,348 | 4.40% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Held | 150,000 | $8,244,000 | 3.47% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Added | 500,000 | $8,060,000 | 3.39% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Held | 200,000 | $8,030,000 | 3.38% | |
| NGNE |
Neurogene Inc.
Healthcare
|
Reduced | 446,814 | $7,743,286 | 3.26% | |
| EPRX |
Eupraxia Pharmaceuticals Inc.
Healthcare
|
NEW | 1,200,000 | $7,080,000 | 2.98% | |
| UPB |
Upstream Bio, Inc.
Healthcare
|
Held | 300,000 | $5,643,000 | 2.38% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
Added | 632,599 | $5,459,329 | 2.30% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Reduced | 80,000 | $5,233,600 | 2.20% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Held | 1,500,000 | $4,905,000 | 2.06% | |
| CNTX |
Context Therapeutics Inc.
Healthcare
|
Held | 4,683,711 | $4,538,515 | 1.91% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
NEW | 155,105 | $3,869,869 | 1.63% | |
| DBVT |
DBV Technologies S.A.
Healthcare
|
Added | 378,594 | $3,785,940 | 1.59% | |
| LEGN |
Legend Biotech Corp
Healthcare
|
Reduced | 113,460 | $3,699,930 | 1.56% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
NEW | 183,330 | $3,525,435 | 1.48% | |
| UNCY |
Unicycive Therapeutics, Inc.
Healthcare
|
Reduced | 796,558 | $3,472,992 | 1.46% | |
| SANA |
Sana Biotechnology, Inc.
Healthcare
|
NEW | 700,000 | $2,485,000 | 1.05% | |
| ABSI |
Absci Corp
Healthcare
|
NEW | 796,438 | $2,421,171 | 1.02% | |
| HRMY |
Harmony Biosciences Holdings, Inc.
Healthcare
|
NEW | 85,000 | $2,342,600 | 0.99% | |
| PLRX |
Pliant Therapeutics, Inc.
Healthcare
|
Held | 850,000 | $1,258,000 | 0.53% | |
| CAPR |
Capricor Therapeutics, Inc.
Healthcare
|
NEW | 87,700 | $632,317 | 0.27% |